Dr. Jean Lud Cadet, Chief of Molecular Neuropsychiatry Branch at the National Institutes of Health joins host Dr. Larry Kaskel to explain a recent study in which he and his colleagues studied cardiovascular impacts of heavy marijuana use. What impact does heavy marijuana use have on apolipoprotein C3 (apoC3)? How does this effect triglyceride levels. Join us to learn more.
Heavy Marijuana Use and Triglycerides Levels
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. Jean Lud Cadet, Chief of Molecular Neuropsychiatry Branch at the National Institutes of Health joins host Dr. Larry Kaskel to explain a recent study in which he and his colleagues studied cardiovascular impacts of heavy marijuana use. What impact does heavy marijuana use have on apolipoprotein C3 (apoC3)? How does this effect triglyceride levels. Join us to learn more.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
FCS and SHTG: Are We Meeting the Need?
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
NYHA FC and Finerenone Response: Clinical Trial Insights
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?